Covidien promoted Jose (Joe) Almeida to president and CEO effective July 1, replacing Richard Meelia, who is retiring. Almeida has served as president of Covidien’s medical devices business unit, its largest business, since 2006 and was credited with increasing its sales at a 9% compounded annual growth rate and introducing more than 70 products. He joined the company, then known as Tyco Healthcare, in 1995.
Human Genome Sciences (HGS) appointed George Morrow, a former Amgen executive, to its board of directors. From April 2003 until January 31, 2011, Morrow was EVP, global commercial operations, for Amgen and launched multiple products in various global markets. He formerly served on the board of GlaxoWellcome, the legacy company of GlaxoSmithKline, which is co-marketing lupus drug Benlysta with HGS.
